Biomarkers for Cancer Diagnosis

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to predict how aggressively your cancer will grow, and are therefore useful for assessing your prognosis, the most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to.


    Related Conference of Biomarkers for Cancer Diagnosis

    December 11-12, 2023

    8th International Anesthesia and Pain Medicine Conference

    Istanbul, Turkey
    January 25-26, 2024

    9th World Congress on Public Health and Nutrition

    London, UK
    February 22-23, 2024

    6th World Summit on Women’s Health and Cancer Awareness

    Zurich, Switzerland
    February 22-23, 2024

    13th International Conference on Epidemiology & Public Health

    Zurich, Switzerland
    March 27-28, 2024

    6th International Conference on Digital Health

    London, UK
    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Amsterdam, Netherlands
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France

    Biomarkers for Cancer Diagnosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in